Commissioner Nominee Crawford Must Answer “Tough Questions” – Grassley
This article was originally published in The Gray Sheet
Executive Summary
Senate Finance Committee Chair Charles Grassley (R-Iowa) is noncommittal on FDA Acting Commissioner Lestor Crawford's nomination to fill the post on a permanent basis
You may also be interested in...
FDA Commissioner Crawford: For Device Firms, His Reputation Precedes Him
Device manufacturers are waiting to see whether FDA Commissioner-nominee Lester Crawford will be responsive to their concerns with the user fee program as he grapples with more high-profile food and drug safety issues
FDA Commish Pick Imminent? Crawford Finally May Shed Understudy Role
The White House seems to have selected FDA Acting Commissioner Lester Crawford, PhD/DVM, as its choice to fill the commissioner slot on a permanent basis
Takeda, Astellas Found New JV To Support Japanese Bioventures
Major Japanese companies Takeda, Astellas and SMBC are joining hands to establish a new joint venture with $3.9m capital and based in Japan’s largest biocluster Shonan iPark to help incubate local biopharma start-ups.